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Abstract 
Here we summarize abundant excuses that support the eye detection can be as a noninvasive 
approach to early diagnose some brain disorders, including Alzheimer disease (AD), autism 
spectrum disorder (ASD), schizophrenia (SZ) and major depressive disorder (MDD). Real-time 
ocular responses in everyone are tightly associated with emotional state and cognitive processing 
in the brain. At the eyeball areas, at least changes involved saccades, pupil response, blinking, 
microvascular network morphology and thickness of retinal nerve fiber layer (RNFL) are 
potentially to be candidates of biomarker to screen and evaluate brain disorders. These days 
medical big data will be more accessible especially with the help of advanced artificial intelligence 
(AI) to analyze precisely. Computer vision combined with machine-learning based AI particularly 
deep-learning neural networks sheds a new light on cognitive neuroscience, and many patients 
with psychotic disorders will primarily benefit from this interdisciplinary advance to induce self-
evaluation and real-time intervention on brain disorders. Finally, we call for more AI applications 
going to approach brain disorder issues, meanwhile, AI technology used in brain healthcare should 
be working together with biological intelligence as we are running an AI manifestation for major 
depression.   
 
Introduction 
 
Saying by philosophers long before, the eye is as a window to the soul. Indeed, our retinas located 
at the eyeballs play a critical role in our “soul”, the central nervous system (CNS, controls our 
perception, emotion, cognition and consciousness)1. Predominant sensory input into the human 
brain comes from the vision system begun at eyes. And eye expression is a key compartment of 
facial expression during social communications in daily. Like at Figure 1, A is a happy eye with a 
positive state while B is an anxious eye with a negative emotion. Those may be why the eyes can 
be considered as the window of the brain2. Very recently, Google (or DeepMind) has reported their 
artificial intelligence (AI) algorithms were capable of detecting retinal diseases3,4, and even 
prediction of cardiovascular risk factors through retinal morphology images5. The potential of AI 
application in disease auto-screening will be huge and most likely to be further improved 
combining with advanced machine learning especially deep-learning neural networks. It is also 
quite reasonable for ocular manifestation to noninvasively check brain disorders since the eye is 
an extension of the brain. Brain disorders such as stroke, Parkinson disease (PD), autism, 
Alzheimer disease (AD), depression and schizophrenia, which intensively lead to vast personal 
suffering, enormous financial costs, and an imposing social burden6, have been already indicated 
to be associated with some various ocular changes to some extent during available 
ophthalmological assessments. We propose here it will be promising to assess ocular changes as a 
potential early-biomarker for brain disorders2; mainly because not only the visual system is our 
dominant sensory input in CNS, but also we rely upon a precise timing and accuracy of visual 
signal about our social and physical stimuli for high-order cortex processing and then to do output 
actions rapidly7. With a manifestation of AI application in brain healthcare, big data of many ocular 
parameters in response to brain emotional and cognitive state in real time might be very helpful 
for early detection and evaluation to brain disorders especially with the help of advanced computer 
vision (CV) and deep learning algorithms. Such as, altered microvascular network and thickness 
of the retinal nerve fiber layer (RNFL) in human retinas have been accessible for many brain 
disorders to be examined with those retinal images, which obtained from retinal fundus 
photography and optical coherence tomography (OCT), respectively8,9. Here we will uncover a 
novel notion about a potential computation ability is developing for effectively detecting human 
affective and cognitive state based on real-time ocular responses, especially when it is combined 
with currently related big data and advanced machine-learning based AI. 
 
 
 
Figure 1 Eye as a window to uncover healthy state. (A) is a happy and restful eye while (B) is 
an anxious and stressful eye. Note that positive state is more frequently associated with upside 
view of eyes while negative state has more downside view. These images are shown here with the 
permission, obtained from our record of raw data. (C) is a sample of retinal fundus image in color, 
whereas (D) and (E) is the same retinal image but in black and white. Predictions of age and gender 
mainly rely on the features of vasculature and optic disc, as indicated in green color in those images. 
The images of (C)-(E) were adapted from Poplin R, et al.5. 
 
A B 
C D E 
  
Intensive connection between eyes and brain  
 
Retina originates from the neural tube during an embryonic development1. In particular, retinal 
ganglion cells (RGCs) anatomically effect their axons into the brain with huge signal input from 
visual environment2. Approximately 80% of signal input to human brain comes from vision system 
that is begun at eyes, and then eye expression contact for facial expression is one of the key 
components of emotional exchange in the social interaction among people11. In the mammalian 
brains, there are approximately 20 nuclei receiving retinal projections, such as, the lateral 
geniculate nucleus as a cognitive relay to the visual cortex, the superior colliculus responsible for 
visual sensory-motor processing, and the hypothalamus mainly involved in hormone 
photoentrainment10. Ocular actions like gaze, pupil response, and blinking are frequently 
happening at anytime of cognitive processing and emotional expression each person12. Therefore, 
the eye will be the best candidate to be considered as the window to check its brain state, in 
particular, being accessible together with current advance of AI. 
 
Sufficient rationale of eye implications in brain diseases 
 
We can often read what the mind is thinking from how the eye sees, such as in some cases, eye 
widening is for fear expression whereas eye narrowing is for disgust expression11. Lee DH et al 
have demonstrated that eye widening enhances visual field that is good for stimulus detection, 
while eye narrowing increases visual acuity that is beneficial for objective discrimination13,14. 
Moreover, visual attention, pupil response, and spontaneous blink can be regarded as three 
noninvasive and complementary measures for cognitive and emotional state with high temporal 
resolutions12. Attention control involved planning, timing and precision of eye movements is 
underpinned by a neural network spanning cortical, subcortical and cerebellar areas; that has been 
extensively investigated in both humans and non-human primates1516,17, as shown in figure 2. Pupil 
dilation is mainly modulated by the norepinephrine system located at locus coeruleus, which 
controls physiological arousal and attention, used as a measure of subjective task difficulty, mental 
effort and neural gain. Whereas spontaneous eyeblink rate seems to tightly correlate with 
dopamine level in CNS and can reflect computing process involved learning and goal-directed 
behavior12. Thus various ocular alternation has been able to use for timely detection and evaluation 
to brain disorders through ophthalmological assessments to those patients, particularly since 
similar embryological origin, anatomical features, and physiologic properties in retinas are 
commonly shared with their brains. It is well-known that retinal microvasculature can be 
noninvasively visualized, quantified and monitored by retinal fundus photography; that provides 
a promising insight into a contribution of microvascular anomaly to stroke and dementia (including 
AD) at least8. Moreover, an increased error occurrence for saccade direction and its timing were 
highly correlated with the severity of Huntington’s disease (HD)18, whereas a significantly low 
eyeblink rate was detected in patients with Parkinson’s disease (PD)19. More typical eye 
implications in brain disorders will be described detailly in below. 
 
 
 
 
Figure 2 Brain neural network involved visually cognitive function. (A) Saccadic eye 
movements for attention controlling involved in complex neural network spanning cortical, 
subcortical and cerebellar areas. The image was adapted from Johnson, BP et al.20. Red arrows 
indicate the direct pathway (PEF, FEF, SEF) to SC and brainstem premotor regions, while yellow 
lines indicate the indirect pathway to the SC and brainstem premotor regions via the basal ganglia 
(striatum, subthalamic nucleus, globus pallidus and substantianigra pars reticula). (B) An 
A B 
architecture model of the cortical hierarchy, adapted from Felleman DJ and Van DE21, is almost 
the best map in terms of cortex circuitry network. There is feedforward, ascending pathways of 
vision system from retina to cortex, with a feedback, descending pathways from cortex to multiple 
downstream areas. 
 
Alzheimer’s disease (AD): fruitful features shown in eyes 
 
In terms of ocular assessment, patients with Alzheimer’s disease (AD) are often known as some 
saccade dysfunctions with the poor visual attention, in particular, unable to focus on a fixed object 
normally9. Also, it was firstly described by Prettyman et al. in 199722, 75% latency of normal pupil 
size was found in pupil constriction in AD patients compared with those in age-matched control. 
Interestingly, the altered pupil response in AD patients is possibly related with the degeneration of 
melanopsin-expressing RGCs that mainly contributed to circadian rhythm function23. Compared 
to age-matched ones, AD patients have markedly shown decreased visual contrast sensitivity, and 
even sensitive to the test at the early stage of AD24. In a large-scale study (n = 426), AD patients 
have altered microvascular network in theirs retinas including narrower retinal venules, a sparser 
and more tortuous retinal vessels25. And it was also found significantly reduced retinal blood flow 
and narrower blood column diameter in AD patients using retinal laser Doppler flowmetry26. 
Gradual and significant decrease in terms of RNFL thickness especially in superior quadrant was 
found from mild cognitive impairment to severe AD compared to that in control using OCT27,28. 
Thus taken together of those multiple features shown in AD’s retinas, it is very likely to get a 
distinctive biomarker with machine learning analysis for AD, even at the early stage for this 
disease29.  
 
Autism spectrum disorder (ASD): specific features with no eye contact 
Lack of normal eye contact during social communication in daily is one of main symptoms of 
autism spectrum disorder (ASD), almost featured in every primary screening and diagnosis30. An 
observation on the decline of eye fixation at 2-6 months old using ophthalmological assessment 
provides a novel way to conduct early evaluation and even intervention for kids with ASD31. 
Moreover, some analysis showed evidence for ocular motor dysfunction in ASD, specifically 
relating to saccade dysmetria (overshooting or undershooting visual targets), difficulty inhibiting 
saccades and impaired tracking of moving targets20. Saccade dysmetria is very likely due to 
dysfunctional neural network that regulates ocular motor control, from the cerebellar vermal-
fastigial circuitry to the brainstem premotor nuclei32,33. The difficulty to inhibit reflexive saccades 
during the anti-saccade task, is associated with restricted and repetitive behavior in ASD, and 
possibly involves in a hyperactivation of FEF and anterior cingulate cortex as conflict monitoring 
neural circuitry34,35. The capability to track a moving objects significantly impaired in ASD; that 
involved in a decreased V5 activation with a reduced top-down modulation of sensorimotor 
processing36. In addition, measured with the flash electroretinogram (ERG) for retinal functions, a 
decrease of the rod b-wave amplitude was present in autistic probands37. 
 
Schizophrenia (SZ): to see or not to see 
 
Visual processing impairment is commonly observed in patients with schizophrenia. Their retinal 
anomalies maybe serve as biomarkers for early diagnosis and intervention to schizophrenia38. 
Other related alterations involved ocular responses were repeatedly found in SZ, the most 
consistent findings among them included:  i) widened retinal venules; ii) the thinning of the RNFL; 
and iii) abnormal ERG amplitudes associated with neurotransmitter deregulation38,39. An 
association between wider retinal venules and severity of psychotic symptoms was reported by a 
twin study40, suggesting the use of retinal venule widening as a proxy biomarker of familial risk 
for SZ. The thinning of RNFL, meaning some retinal ganglion cell loss, has been frequently 
observed in patients with SZ by OCT with high resolution41,42, but which is also found in patients 
with Parkinson’s disease43 and Alzheimer’s disease44. Abnormality in electroretinogram (ERG) 
can reflect deregulation of neurotransmitters such as  dopamine transmitter in the retina, the change 
of which is correlated with that in the brain45,46. Those anomalies detected by ERG in schizophrenia 
include reduced functions of photoreceptors (both rod and cone) and bipolar cells, and also 
abnormal function of RGCs with flash ERG test. A portable ERG device  seems to be capable of 
detecting the retinal anomalies, might facilitate its  application in ordinary mental health clinics47. 
 
Major depressive disorder (MDD): a gray world in the view of depressive people 
 
As described in many languages and artworks, major depressive disorder (MDD) is often 
associated with dark, gray and black colors, since everything is said to look gray-in-gray with a 
depressive view when people feel blue. Interestingly, a finding of reduced contrast sensitivity at 
the depressed patients is supported this notion; unmedicated and medicated patients with 
depression showed significantly reduced retinal contrast sensitivity48. There is even a strong 
correlation between contrast gain and depression severity using pattern ERG to record48,49. Patients 
with MDD have performed less well compared to healthy controls in the anti-saccade task, 
including elevated error rates and increased reaction time50,51. Moreover, compared with healthy 
control and non-melancholic depression, melancholic depression seemed to be more associated 
with the longer latency, reduced peak velocity and hypometric primary saccade during saccadic 
eye movement tasks52. It has been clearly investigated that melanopsin-expressing ipRGCs 
contributed to the pupil response function particularly for sustained-state pupil constriction53,54, 
consistent with the ipRGCs capability of firing without tiredness in response to continuous 
stimulation of blue light (470 nm)55. In patients with seasonal affective disorder (SAD, namely, 
winter depression), there is a significantly reduced post-illumination pupil response (PIPR) and 
also a lower PIPR percent change in response to blue light stimuli using infrared pupillometry to 
measure56,57. However, the PIPR with the blue stimulation changed only in patients carrying the 
OPN4 I394T genotype rather than OPN4 P10L genotype56. 
 
As described in above, brain disorders often belong to complicated issues even just shown their 
features at eyes. Some anomalies detected at the ocular responses can be specific to some disorders, 
whereas others seemed to be shared by many ones (Table 1). And some features come from a 
neurodevelopmental origin with a high genetic risk, while others may be partially influenced by 
psychiatric medication46. Vastly psychical and economic burden in human society caused by brain 
disorders calls for an assistance of machine-learning based AI. For this, currently, a wearable smart 
glasses we are developing (patent in process), will be used for collecting multiple data of ocular 
parameters at least involved saccades, pupil response and blinking; and also combining with 
computing platform such as smart phone to perform related AI algorithms. 
 
 Table 1 Multiple changes of ocular parameters are associated with brain disorders using 
available ophthalmological assessments 
 
 Saccades Pupil RNFL Microvessel ERG / else 
 
 
Alzheimer’s 
disease 
Poor eye 
fixation9 
Delayed 
pupil 
constriction22, 
23 
Reduced 
RNFL 
thickness 
especially in 
superior 
quadrant24,25 
Narrower 
retinal venules, a 
sparser and 
more tortuous 
retinal vessels25 
Markedly 
decreased 
contrast 
sensitivity24 
 
 
 
 
 
 
Autism 
 
 
 
Decline eye 
fixation at 
2-6 months 
old31; 
saccade 
dysmetria20; 
impaired 
tracking of 
moving 
targets36 
 
 
 
 
 
--- 
 
 
 
 
 
--- 
 
 
 
 
 
--- 
 
 
 
 
 
Decreased 
rod b-wave 
amplitude in 
flash ERG37 
 
 
 
Schizophrenia 
 
 
 
--- 
 
 
 
--- 
 
 
 
Thinning of 
RNFL41,42 
 
 
 
Widened retinal 
venules40 
Abnormal 
ERG 
amplitudes 
including 
rod, cone,  
bipolar cells 
and 
RGCs42,43,47 
 
 
 
 
 
Major 
depression 
 
 
 
Elevated 
error rates 
and an 
increased 
reaction 
time50,51 
 
 
Reduced 
PIPR and a 
lower PIPR 
percent 
change in 
response to 
blue light in 
SAD56 
 
 
 
 
 
--- 
 
 
 
 
 
--- 
 
 
 
Significantly 
reduced 
contrast 
sensitivity 
using 
pattern 
ERG48,49 
 
 
 
 
 
Computer vision (CV) to see brain state through eyes 
 
So far computer vision (CV) seems to be as the most powerful tool to push AI application into 
healthcare areas, exhibiting a high capability of auto-screening diseases at least for skin cancer58, 
diabetic retinopathy3,59, and major depression60. Since people can read many complex emotional 
and cognitive states from facial especially eye expression of other people, such as fear, fatigue and 
absence of mind, it is very likely that AI based CV is also able to do the same. With a dramatic 
development of machine-learning based AI, very recently, CV with its superior resolution seems 
to be close to this step by step. Many people with psychiatric disorders will benefit from AI 
application in brain healthcare, particularly to help them monitor symptoms by themselves, 
conduct intervention in real time and recovery social ability effectively. Recognizing human 
emotional and cognitive state correctly is a priority step and it is an accessible approach to achieve 
through reading our ocular responses at real time. However, current CV used for facial expression 
recognition often neglects the eye movement and other main ocular responses that usually contain 
abundant information for human affective state. It is time to change this situation with more 
advances came from AI engagement. In particular, Google AI applications at retinas showed 
accessible health information hiding there and that can obtain from retina imaging noninvasively 
and conveniently3,4. Eye as the window of soul is definitely deserved to be opened, where the 
health information can be obtained much, not only eye diseases but also cardiovascular risk 
factors5, and even brain cognitive state as described in Table 1.   
Recently, AI tech has already started to shed a new light on brain disorders. Cognoa applied clinical 
data with gold standard of autism, which obtained from thousands of children at-risk for ASD, to 
train and develop an AI platform. That product can provide earlier diagnostics and probably 
personalized therapeutics for autism61, already got an approval of FDA last year. In order to further 
achieve automatic perception of the children’s affective state and engagement during the robot-
assisted autism therapy, Rudovic et al have made a personalized machine learning framework with 
deep learning algorithms62. In terms of auto-screening depression, Alhanai et al used audio and 
text features to train a neural network of long-short term memory that was comparable to 
traditional method with questionnaire63. Haque A et al trained their AI using spoken language and 
3D facial expressions that were commonly available from smart phones to measure depression 
severity, with 83.3% of sensitivity and 82.6% of specificity60. However, the 3D facial scans in that 
study were so low resolution (68 pixels) that there were not enough information to measure facial 
especially ocular parameters60. Currently, we are running a project to develop an AI platform that 
utilizes those ocular data to train model, in order to make a computing capability of detecting 
depressive state in real time. This AI platform will be able to conduct the qualification of brain 
emotional and cognitive state and that mainly bases on the input of real-time ocular responses. Its 
core function can be obtained accessibly through either an ordinary smart phone or a wearable 
smart glasses that we are making. 
 
Discussion and prospective 
Medical issues involved challenging diseases of human being are often tightly associated with big 
data, then AI algorithms enables big data to be powerful according to very recently accumulating 
evidence64. Although AI application going to medicine is just at beginning, AI-based force to 
automatic diagnosis has already contributed to several cancers and retinal diseases58,3,59. And more 
reports on AI practices in medical diagnosis have stayed at the preprint form without peer-reviewed 
publication yet, which most involved image recognition using deep neural networks (DNN) with 
supervised learning, at least helping effectively interpret medical scans65, pathological slides66, and 
retinal images67. Since retinal images were relatively easy to obtain using fundus imaging or OCT 
without any invasion and the diagnostic standards of eye diseases have become well-defined, AI 
performance has been frequently showed in the ophthalmology. Many eye diseases have seemed 
to be already assessed by deep-learning neural networks, at least including diabetic retinopathy68, 
age-related macular degeneration69, congenital cataracts70, and so on; and majority of them 
exhibited remarkable accuracy comparable with that of eye specialists64. Brain disorders are often 
more complicated than other medical issues, leading to enormous burden in human society, such 
as, currently at least 350 million people are suffering from major depression in the world71. There 
is huge potential for AI to lend its support to those patients with affective disorders and the 
insufficient number of clinicians as well. Utility of AI algorithms to detect abnormal ocular 
responses associated with brain disorders is at least worth testing for its feasibility and efficacy, 
since it is well-known that the eye is as the window of the brain with the majority of key input 
signal from eyes into brain and also fruitful eye expression exhibited in social communication. CV 
on ocular response with AI algorithms seems to be a promising tool to noninvasively detect the 
differences in ocular responses11, particularly associated with brain disorders such as autism, major 
depression, schizophrenia, Parkinson disease (PD) and Alzheimer disease (AD). However, the 
capability of emotional recognition with AI algorithms is required to reach more at the quantitative 
level rather than only at the qualitative level, in order to achieve the qualification of human 
emotional and cognitive state at real time especially for brain disorders.   
Currently, a crucial issue is how to collect data with a high quality to be obtained valid features by 
AI algorithms effectively. In terms of AI recognition to facial expression, high-resolution imaging 
is required to collect if that will move forward to approach brain disorder issue. Since eye 
expression plays a key role in social communication, multiple ocular data should not be neglected 
for emotional understanding. Some parameters like eye movement, pupil response and blinking 
rate that usually contain more detail information on human affective state12. And micro-expression 
detection is sometimes required for ground truth of facial expression72. Those features are unable 
to be shown by still images but needing dynamic videos with continue image frames. In addition, 
high resolution of imaging is potentially beneficial to obtain more healthcare data from face skin 
using photoplethysmography (PPG) technique73,74, such as heart rate variability and blood oxygen 
saturation72.  
Another issue is from argument of privacy protection when facial data is hoped to obtain as 
informative as possible to produce AI algorithms75. Firstly, participants need to be provided a 
consent issue about data collection, and the study staff will advise participants of their rights as in 
medical research and summarize what is expected for participation into the study. Then an 
important strategy for protecting participants from privacy breach is deidentifying their data by 
removing specified identifiers, like names and phone numbers75. In our pilot design, all facial or 
ocular data will be obtained and stored by participants themselves through their mobile phones, 
and they definitely have rights to decide if data enables sharing without identifying information. 
And those collected data from participants is only accessed by our research members to train and 
create AI algorithms.  
In addition, some costly equipment are required for harvesting data, precisely, but often not 
portably and accessibly, such as fMRI for depression scan76 and CT for head trauma screen77. 
Some portable or wearable devices are considered to develop for brain healthcare since it will be 
good for detecting the related symptoms involved brain disorders as early as possible, rather than 
just auto-diagnosing them at the later and severe stage. We are developing a wearable smart glasses 
(patent in process), which can collect many kinds of parameters involved ocular responses at least 
including saccades, pupil response, and blinking parameters; other biological data with EEG and 
PPG techniques can be considered to get together as well. It will be powerful to detect and evaluate 
brain state at real time with AI algorithms; that is more likely to predict, prevent and intervene 
brain disorders as early as possible. 
A story of bringing AI into brain healthcare is just beginning, yet the integration of human 
biological intelligence (BI) and machine-learning based AI has required but barely begun. Brain 
belongs to the most complicated CNS system so that brain healthcare will become one of the most 
challenging issues human being need to approach. Only AI is insufficient, we all know, to process 
brain disorders, since current machine learning is totally depending on collected data. The quality 
of collected data is quite important to be ensured, certainly needing a favor from our BI including 
the related knowledge, information and statistics. Taken AI recognition for facial expression as an 
example again, AI performance is so far just at the qualitative level, often known as 7 basic 
expressions with some composite expressions78. It will and can be moved forward into more with 
the quantitative level, based on BI combination especially from cognitive neuroscience. Obtaining 
fruitful information on ocular responses with advanced device and AI technology, we perhaps 
learn clearly about the threshold value of brain disorders distinguished from brain normality and 
know more about specific features for different brain disorders; that will be beneficial to conduct 
effective prevention and treatment for brain disorders as early as possible. Certainly, machine-
learning based AI especially deep-learning neural network can also get more inspiration from 
further advance of brain neuroscience79. Last but not least, brain disorders can be assessed by 
ocular detection while that certainly needs to consider the exclusion of the eye disease situation 
and that well-trained AI will offer its support again4. Eventually, advanced AI will help those 
patients with brain disorders directly and currently, differing from gene therapy that often plans to 
offer new prospective for the next generation of psychiatric patients, through auto-detection with 
AI algorithms, self-evaluation with wearable sensors and timely-intervention with human-
computer interaction as well. May the force of AI be with patients of brain disorders particularly 
using a promising approach to detect ocular responses in real time. 
 
 
 
Acknowledgements  
This article was supported by grants from the Commission on Innovation and Technology in 
Shenzhen Municipality of China (JCYJ20150630114942262), the International Postdoctoral 
Exchange Fellowship Program 2016 by the Office of China Postdoctoral Council (20160021), and 
the Hugo Shong fellowship supporting for postdoctoral research at McGovern Institute for Brain 
Research, MIT. Also, thanks to the help of Venture Mentoring Service (VMS), MIT. 
 
 
 
Ref: 
 
1 Dowling, J. E. The retina: an approachable part of the brain.  (Harvard University Press, 1987). 
2 London, A., Benhar, I. & Schwartz, M. The retina as a window to the brain—from eye research to CNS 
disorders. Nature Reviews Neurology9, 44 (2013). 
3 Gulshan, V. et al. Development and validation of a deep learning algorithm for detection of diabetic 
retinopathy in retinal fundus photographs. JAMA : the journal of the American Medical Association316, 
2402-2410 (2016). 
4 De Fauw, J. et al. Clinically applicable deep learning for diagnosis and referral in retinal disease. Nature 
medicine24, 1342 (2018). 
5 Poplin, R. et al. Prediction of cardiovascular risk factors from retinal fundus photographs via deep learning. 
Nature Biomedical Engineering2, 158 (2018). 
6 Lopez, A. D. & Murray, C. C. The global burden of disease, 1990–2020. Nature medicine4, 1241 (1998). 
7 Cotti, J., Vercher, J.-L. & Guillaume, A. Hand–eye coordination relies on extra-retinal signals: Evidence from 
reactive saccade adaptation. Behavioural brain research218, 248-252 (2011). 
8 Cheung, C. Y., Chen, C. & Wong, T. Y. in Seminars in neurology.  481-490 (Thieme Medical Publishers). 
9 Javaid, F. Z., Brenton, J., Guo, L. & Cordeiro, M. F. Visual and ocular manifestations of Alzheimer’s disease 
and their use as biomarkers for diagnosis and progression. Frontiers in neurology7, 55 (2016). 
10 Li, X. & Li, X. The antidepressant effect of light therapy from retinal projections. Neuroscience bulletin, 1-10 
(2018). 
11 Lee, D. H. & Anderson, A. K. Reading what the mind thinks from how the eye sees. Psychological science28, 
494-503 (2017). 
12 Eckstein, M. K., Guerra-Carrillo, B., Singley, A. T. M. & Bunge, S. A. Beyond eye gaze: What else can 
eyetracking reveal about cognition and cognitive development? Developmental cognitive neuroscience25, 
69-91 (2017). 
13 Lee, D. H., Mirza, R., Flanagan, J. G. & Anderson, A. K. Optical origins of opposing facial expression actions. 
Psychological science25, 745-752 (2014). 
14 Lee, D. H., Susskind, J. M. & Anderson, A. K. Social transmission of the sensory benefits of eye widening in 
fear expressions. Psychological science24, 957-965 (2013). 
15 Jamadar, S., Fielding, J. & Egan, G. Quantitative meta-analysis of fMRI and PET studies reveals consistent 
activation in fronto-striatal-parietal regions and cerebellum during antisaccades and prosaccades. Frontiers 
in psychology4, 749 (2013). 
16 Hikosaka, O., Takikawa, Y. & Kawagoe, R. Role of the Basal Ganglia in the Control of Purposive Saccadic Eye 
Movements. Physiological Reviews80, 953-978, doi:10.1152/physrev.2000.80.3.953 (2000). 
17 Baier, B., Stoeter, P. & Dieterich, M. Anatomical correlates of ocular motor deficits in cerebellar lesions. Brain : 
a journal of neurology132, 2114-2124 (2009). 
18 Peltsch, A., Hoffman, A., Armstrong, I., Pari, G. & Munoz, D. Saccadic impairments in Huntington’s disease. 
Experimental brain research186, 457 (2008). 
19 Agostino, R. et al. Voluntary, spontaneous, and reflex blinking in Parkinson's disease. Movement Disorders23, 
669-675 (2008). 
20 Johnson, B. P., Lum, J. A., Rinehart, N. J. & Fielding, J. Ocular motor disturbances in autism spectrum 
disorders: Systematic review and comprehensive meta-analysis. Neuroscience & Biobehavioral Reviews69, 
260-279 (2016). 
21 Felleman, D. J. & Van, D. E. Distributed hierarchical processing in the primate cerebral cortex. Cerebral cortex 
(New York, NY: 1991)1, 1-47 (1991). 
22 Prettyman, R., Bitsios, P. & Szabadi, E. Altered pupillary size and darkness and light reflexes in Alzheimer's 
disease. Journal of Neurology, Neurosurgery & Psychiatry62, 665-668 (1997). 
23 La Morgia, C. et al. Melanopsin retinal ganglion cell loss in A lzheimer disease. Annals of neurology79, 90-
109 (2016). 
24 Risacher, S. L. et al. Visual contrast sensitivity in Alzheimer’s disease, mild cognitive impairment, and older 
adults with cognitive complaints. Neurobiology of aging34, 1133-1144 (2013). 
25 Cheung, C. Y.-l. et al. Microvascular network alterations in the retina of patients with Alzheimer's disease. 
Alzheimer's & Dementia10, 135-142 (2014). 
26 Feke, G. T., Hyman, B. T., Stern, R. A. & Pasquale, L. R. Retinal blood flow in mild cognitive impairment and 
Alzheimer's disease. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring1, 144-151 
(2015). 
27 Valenti, D. A. Neuroimaging of retinal nerve fiber layer in AD using optical coherence tomography. 
Neurology69, 1060-1060 (2007). 
28 Liu, D. et al. Thinner changes of the retinal nerve fiber layer in patients with mild cognitive impairment and 
Alzheimer’s disease. BMC neurology15, 14 (2015). 
29 Mutlu, U. et al. Association of retinal neurodegeneration on optical coherence tomography with dementia: 
a population-based study. JAMA neurology75, 1256-1263 (2018). 
30 Lord, C., Rutter, M., DiLavore, P. C. & Risi, S. Autism diagnostic observation schedule-WPS (ADOS-WPS). Los 
Angeles, CA: Western Psychological Services (1999). 
31 Jones, W. & Klin, A. Attention to eyes is present but in decline in 2–6-month-old infants later diagnosed with 
autism. Nature504, 427 (2013). 
32 Barash, S. et al. Saccadic dysmetria and adaptation after lesions of the cerebellar cortex. Journal of 
Neuroscience19, 10931-10939 (1999). 
33 Scudder, C. A., Kaneko, C. R. & Fuchs, A. F. The brainstem burst generator for saccadic eye movements. 
Experimental brain research142, 439-462 (2002). 
34 Agam, Y., Joseph, R. M., Barton, J. J. & Manoach, D. S. Reduced cognitive control of response inhibition by 
the anterior cingulate cortex in autism spectrum disorders. Neuroimage52, 336-347 (2010). 
35 Thakkar, K. N. et al. Response monitoring, repetitive behaviour and anterior cingulate abnormalities in 
autism spectrum disorders (ASD). Brain : a journal of neurology131, 2464-2478 (2008). 
36 Takarae, Y., Minshew, N. J., Luna, B., Krisky, C. M. & Sweeney, J. A. Pursuit eye movement deficits in autism. 
Brain : a journal of neurology127, 2584-2594 (2004). 
37 Realmuto, G., Purple, R., Knobloch, W. & Ritvo, E. Electroretinograms (ERGs) in four autistic probands and 
six first-degree relatives. The Canadian Journal of Psychiatry34, 435-439 (1989). 
38 Silverstein, S. M. & Rosen, R. Schizophrenia and the eye. Schizophrenia Research: Cognition2, 46-55 (2015). 
39 Adams, S. A. & Nasrallah, H. A. Multiple retinal anomalies in schizophrenia. Schizophrenia research195, 3-
12 (2018). 
40 Meier, M. H. et al. Retinal microvessels reflect familial vulnerability to psychotic symptoms: A comparison 
of twins discordant for psychotic symptoms and controls. Schizophrenia research164, 47-52 (2015). 
41 Lee, W. W., Tajunisah, I., Sharmilla, K., Peyman, M. & Subrayan, V. Retinal nerve fiber layer structure 
abnormalities in schizophrenia and its relationship to disease state: evidence from optical coherence 
tomography. Investigative ophthalmology & visual science54, 7785-7792 (2013). 
42 Cabezon, L. et al. Optical coherence tomography: a window into the brain of schizophrenic patients. Acta 
Ophthalmologica90 (2012). 
43 Satue, M. et al. Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson’s 
disease patients. Eye27, 507 (2013). 
44 M Moschos, M. et al. Structural and functional impairment of the retina and optic nerve in Alzheimer's 
disease. Current Alzheimer Research9, 782-788 (2012). 
45 Lavoie, J. et al. The electroretinogram as a biomarker of central dopamine and serotonin: potential relevance 
to psychiatric disorders. Biological psychiatry75, 479-486 (2014). 
46 Lavoie, J., Maziade, M. & Hébert, M. The brain through the retina: the flash electroretinogram as a tool to 
investigate psychiatric disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry48, 129-
134 (2014). 
47 Demmin, D. L., Davis, Q., Roché, M. & Silverstein, S. M. Electroretinographic anomalies in schizophrenia. 
Journal of abnormal psychology127, 417 (2018). 
48 Bubl, E., Kern, E., Ebert, D., Bach, M. & Van Elst, L. T. Seeing gray when feeling blue? Depression can be 
measured in the eye of the diseased. Biological psychiatry68, 205-208 (2010). 
49 Bubl, E., Ebert, D., Kern, E., van Elst, L. T. & Bach, M. Effect of antidepressive therapy on retinal contrast 
processing in depressive disorder. The British Journal of Psychiatry201, 151-158 (2012). 
50 Harris, M. S., Reilly, J. L., Thase, M. E., Keshavan, M. S. & Sweeney, J. A. Response suppression deficits in 
treatment-naive first-episode patients with schizophrenia, psychotic bipolar disorder and psychotic major 
depression. Psychiatry research170, 150-156 (2009). 
51 Malsert, J. et al. Antisaccades as a follow-up tool in major depressive disorder therapies: a pilot study. 
Psychiatry research200, 1051-1053 (2012). 
52 Winograd-Gurvich, C., Georgiou-Karistianis, N., Fitzgerald, P., Millist, L. & White, O. Ocular motor differences 
between melancholic and non-melancholic depression. Journal of affective disorders93, 193-203 (2006). 
53 Gamlin, P. D. et al. Human and macaque pupil responses driven by melanopsin-containing retinal ganglion 
cells. Vision research47, 946-954 (2007). 
54 Adhikari, P., Pearson, C. A., Anderson, A. M., Zele, A. J. & Feigl, B. Effect of age and refractive error on the 
melanopsin mediated post-illumination pupil response (PIPR). Scientific reports5, 17610 (2015). 
55 Güler, A. D. et al. Melanopsin cells are the principal conduits for rod–cone input to non-image-forming vision. 
Nature453, 102 (2008). 
56 Roecklein, K. et al. The post illumination pupil response is reduced in seasonal affective disorder. Psychiatry 
research210, 150-158 (2013). 
57 La Morgia, C., Carelli, V. & Carbonelli, M. Melanopsin retinal ganglion cells and pupil: clinical implications for 
neuro-ophthalmology. Frontiers in neurology9 (2018). 
58 Esteva, A. et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature542, 115 
(2017). 
59 Ting, D. S. W. et al. Development and validation of a deep learning system for diabetic retinopathy and 
related eye diseases using retinal images from multiethnic populations with diabetes. JAMA : the journal of 
the American Medical Association318, 2211-2223 (2017). 
60 Haque, A., Guo, M., Miner, A. S. & Fei-Fei, L. Measuring Depression Symptom Severity from Spoken Language 
and 3D Facial Expressions. arXiv preprint arXiv:1811.08592 (2018). 
61 Abbas, H., Garberson, F., Glover, E. & Wall, D. P. Machine learning approach for early detection of autism by 
combining questionnaire and home video screening. Journal of the American Medical Informatics 
Association (2017). 
62 Rudovic, O., Lee, J., Dai, M., Schuller, B. & Picard, R. W. Personalized machine learning for robot perception 
of affect and engagement in autism therapy. Science Robotics3, eaao6760, doi:10.1126/scirobotics.aao6760 
(2018). 
63 Al Hanai, T., Ghassemi, M. & Glass, J. in Proc. Interspeech.  1716-1720. 
64 Topol, E. J. High-performance medicine: the convergence of human and artificial intelligence. Nature 
medicine25, 44 (2019). 
65 Schnyer, D. M., Clasen, P. C., Gonzalez, C. & Beevers, C. G. Evaluating the diagnostic utility of applying a 
machine learning algorithm to diffusion tensor MRI measures in individuals with major depressive disorder. 
Psychiatry Research: Neuroimaging264, 1-9 (2017). 
66 Steiner, D. F. et al. Impact of deep learning assistance on the histopathologic review of lymph nodes for 
metastatic breast cancer. The American journal of surgical pathology42, 1636-1646 (2018). 
67 Abràmoff, M. D., Lavin, P. T., Birch, M., Shah, N. & Folk, J. C. Pivotal trial of an autonomous AI-based 
diagnostic system for detection of diabetic retinopathy in primary care offices. npj Digital Medicine1, 39 
(2018). 
68 Kanagasingam, Y. et al. Evaluation of artificial intelligence–based grading of diabetic retinopathy in primary 
care. JAMA network open1, e182665-e182665 (2018). 
69 Burlina, P. M. et al. Automated grading of age-related macular degeneration from color fundus images using 
deep convolutional neural networks. JAMA ophthalmology135, 1170-1176 (2017). 
70 Long, E. et al. An artificial intelligence platform for the multihospital collaborative management of 
congenital cataracts. Nature biomedical engineering1, 0024 (2017). 
71 Vos, T. et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a 
systematic analysis for the Global Burden of Disease Study 2010. Lancet380, 2163-2196, doi:10.1016/s0140-
6736(12)61729-2 (2012). 
72 Oh, Y.-H., See, J., Le Ngo, A. C., Phan, R. C.-W. & Baskaran, V. M. A Survey of Automatic Facial Micro-
expression Analysis: Databases, Methods and Challenges. Frontiers in psychology9, 1128 (2018). 
73 McDuff, D., Gontarek, S. & Picard, R. in 2014 36th Annual International Conference of the IEEE Engineering 
in Medicine and Biology Society.  2957-2960 (IEEE). 
74 McDuff, D., Gontarek, S. & Picard, R. W. Improvements in remote cardiopulmonary measurement using a 
five band digital camera. IEEE Transactions on Biomedical Engineering61, 2593-2601 (2014). 
75 Price, W. N. & Cohen, I. G. Privacy in the age of medical big data. Nature medicine25, 37 (2019). 
76 Drysdale, A. T. et al. Resting-state connectivity biomarkers define neurophysiological subtypes of depression. 
Nature medicine23, 28 (2017). 
77 Chilamkurthy, S. et al. Deep learning algorithms for detection of critical findings in head CT scans: a 
retrospective study. The Lancet392, 2388-2396 (2018). 
78 Ko, B. A brief review of facial emotion recognition based on visual information. sensors18, 401 (2018). 
79 Ullman, S. Using neuroscience to develop artificial intelligence. Science363, 692-693 (2019). 
 
 
